Abstract
Introduction Pregnant people have a higher risk of severe COVID-19 disease. They have been disproportionately impacted by COVID-19 infection control policies, which exacerbated conditions resulting in intimate partner violence, healthcare access, and mental health distress. This project examines the impact of accumulated individual health decisions and describes how perinatal care and health outcomes changed during the COVID-19 pandemic.
Objectives
Quantitative strand: Describe differences between 2019, 2021, and 2022 birth groups related to maternal vaccination, perinatal care, and mental health care. Examine the differential impacts on racialized and low-income pregnant people.
Qualitative strand: Understand how pregnant people’s perceptions of COVID-19 risk influenced their decision-making about vaccination, perinatal care, social support, and mental health.
Methods and analysis This is a Canadian convergent parallel mixed-methods study. The quantitative strand uses a retrospective cohort design to assess birth group differences in rates of Tdap and COVID-19 vaccination, gestational diabetes screening, length of post-partum hospital stay, and onset of depression, anxiety, and adjustment disorder, using administrative data from ICES, formerly the Institute for Clinical Evaluative Sciences (Ontario) and PopulationData BC (PopData) (British Columbia). Differences by socioeconomic and ethnocultural status will also be examined. The qualitative strand employs qualitative description to interview people who gave birth between May 2020-December 2021 about their COVID-19 risk perception and health decision-making process. Data integration will occur during design and interpretation.
Ethics and dissemination This study received ethical approval from McMaster University and the University of British Columbia. Findings will be disseminated via manuscripts, presentations, and patient-facing infographics.
Strengths and limitations of this study
Population-based administrative data cohorts are very large, ensuring that analyses are high-powered.
Mixed-methods design will allow us to offer explanation for changes in healthcare use observed through administrative data.
Cross-provincial design permits examination of the potential impacts of COVID-19 infection prevention and control policies on pregnant people’s health.
Use of Canadian Index of Multiple Deprivation will allow us to examine differences in healthcare use according to economic, racial, and immigration factors.
Team includes 5 co-investigators with lived experience of pandemic pregnancies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Our study is registered with clinicaltrials.gov, (NCT05663762).
Funding Statement
This work was supported by Canadian Institutes of Health Research grant number 179921. SDM and MV are supported by a Tier 2 Canada Research Chairs. MM is supported by a Banting Postdoctoral Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Hamilton Integrated Research Ethics Board (HiREB) has reviewed and approved the study (14632, 15100C). The University of British Columbia Research Ethics Board has also reviewed and approved the study (H22-01905). Written consent will be obtained for each qualitative study participant.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Registration: Clinicaltrials.gov registration number: NCT05663762
Data Availability
Qualitative data are not available for sharing when participants consented to participate in the study, they did not consent to access transcripts or data beyond what is reported within this report. The dataset for the quantitative portion of this study is held securely in coded form at ICES and PopData BC. While legal data sharing agreements between these data stewards and data providers prohibit ICES and PopData BC from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access. Readers are welcome to contact the research team for further information.
